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Review Article
Anaesthesia for Caesarean Section in Patients with Cardiac Disease
Ursula Chohan, Gauhar Afshan, Abdul Mone
Department of Anaesthesia, The Aga Khan University Hospital, Karachi.
Abstract
This review contains material sourced from med-line
and pub-med, search year 2002-2004. Material selected was
pertaining to common cardiac ailments in pregnancy.
Congenital cardiac problems i.e. Tetralogy of Fallot (TOF),
Atrial Septal Defect (ASD), Ventricular Septal Defect
(VSD), Eisenmengers syndrome, valvular heart disease, i.e.
mitral stenosis, mitral regurgitation, aortic stensois and aor-
tic regurgitation are discussed.
Other cardiac conditions associated with pregnancy
are pulmonary hypertension and peri-partum cardio-myopa-
thy. Arrhythmias during pregnancy, vary from isolated pre-
mature to supra-ventricular and ventricular tachycardia,
management is similar to non-pregnant patients.
This review summarizes the current management of
a parturient with cardiac disease requiring surgical delivery.
Regional anaesthesia techniques are preferred as reflected
in the current literature for patient with cardiac disease with
minor alterations such as slow establishment of epidural for
caesarean section or continuous spinal anaesthesia with
very small incremental doses of local anaesthesia, maintain-
ing the patient's SVR with vasopressors and fluid, monitor-
ing of the fluid regimen with CVP and in some cardiac func-
tion with Swan Ganz catheter. Patients with Eisenmenger
syndrome, pulmonary hypertension, should be advised to
avoid pregnancy.
In conclusion with vast advancements in obsterics
care, improvements in cardiac surgery, many patients with
cardiac disease can now be safely delivered surgically by
skillful anaesthesiologists who are aware of the common
potential intra-operative problems and the ability to respond
to undesired events immediately.
Introduction
The prevalence of heart disease in pregnancy has
remained relatively constant over the last several decades,
reported incidence is between 0.4-4.1%1
Over the past 2 decades, greater awareness of the
physiologic burden that pregnancy places on an already
compromised cardiovascular system in these parturients,
has lead to an early counseling regarding pregnancy, and in
some patients it may be advisable to avoid conception.
Pregnant patient with heart disease is a unique chal-
lenge to the obstetrician and anesthesiologist, dealing with
high risk parturients and requires a thorough understanding
of the impact of pregnancy on the haemodynamic response
to the patient's cardiac lesion.1
The aim of this review is to discuss the current
anaesthetic management of parturient with common cardiac
conditions, presenting for Caesarean section. Common car-
diac lesions seen during pregnancy in our population, range
from congenital cardiac defects to peri-partum cardiomy-
opathy.  Understanding the physiology of pregnancy and the
patho-physiology of the underlying cardiac disease is
important when providing anaesthesia for these high risk
obstetric patients.  Rheumatic heart disease at present is the
most common cardiac disorder in pregnancy, with mitral
stenosis (MS) as a single most prevalent lesion.1
This review attempts to summarize the current status
of anaesthesia technique for caesarean section in parturients
with underlying cardiac diseases in the Pakistani popula-
tion. The materials included in this review were sourced by
Medline and pub-med search for the year 2004.
1. Congenital Heart Disease (CHD)
Congenital heart disease is becoming the most com-
mon source of cardiac problems seen in pregnant patients.2
Patients are increasingly likely to survive to child bearing
age with the advent of palliative surgery or total correction
of their defects and many of them are expected to have an
uneventful pregnancy and delivery.
Common congenital cardiac defects are Patent
Ductus Arteriosus (PDA), atrial septal defect (ASD) and
ventricular septal defect (VSD). Atrial septal defect is the
most common cardiac congenital lesion in women of child
bearing age, pregnancy is usually well tolerated, and how-
ever risk of LVF is increased during pregnancy2. Due to
increase in the cardiovascular volume during pregnancy
there is increase in the atrial volume which may result in bi-
atrial enlargement, and super-ventricular dysarythmias are
likely to occur.  The anaesthesiologist may be involved in
the management of the patients who have had successful
surgery during infancy and childhood, with complete repair,
asymptomatic with relatively normal intra-cardiac pressures
and blood flow pattern or he may be involved in the man-
agement of patients with uncorrected lesions, which is chal-
lenging and complex. Atrial septal / ventricular septal
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defects in pregnancy are often well tolerated during preg-
nancy.2
When anaesthetizing patients with CHD, using
either a regional technique or general anaesthesia, the fol-
lowing factors must be kept in mind; prevention of acciden-
tal intravenous infusion of air bubbles, when planning
epidural anaesthesia, loss of resistance to saline rather than
air should be used to identify the epidural space3, a slow
onset of epidural analgesia is preferred, as rapid decrease in
systemic vascular resistance (SVR) could result in reversal
of shunt with maternal hypoxaemia.2 Supplemental O2
should be given to the patient throughout the procedure if
regional technique is used. It is advisable to monitor O2 sat-
uration as mild hypoxaemia may result in increased pul-
monary vascular resistance (PVR) and reversal of shunt
flow.  Hypercarbia and acidosis should be avoided, as it may
result in increased PVR and reversal of shunt flow.  
In patients who had successful surgery in infancy or
childhood, no special treatment is required. Antibiotic pro-
phylaxis is recommended.
Tetralogy of Fallot (TOF) - constitutes 15% of all con-
genital cardiac defects (CCD)
TOF is the most common etiologic factor in the right
to left shunt.4 TOF consists of 4 structural abnormalities, i.e.
ventricular septal defect (VSD), right ventricular hypertro-
phy (RVH), pulmonic stenosis, right ventricular outflow
obstruction and overriding of the aorta.
Most pregnant women will have had corrective sur-
gery, which consists of closure of the VSD and widening of
the pulmonary tract.  This surgery is usually successful but
in some patients, a small VSD may reoccur, or progressive
hypertrophy of the pulmonary outflow tract may occur
slowly over the years.5 In patients with history of syncope,
polycythemia, decreased arterial O2 saturation, right ven-
tricular hypertension and congestive cardiac failure (CCF)
are particularly at risk.  
Patients with successful correction of TOF need no
special treatment, except antibiotic prophylaxis and meticu-
lous care to prevent any air entry into the circulation.  In
patients with uncorrected lesion, anaesthetic considerations
must focus on minimizing the haemodynamic changes that
would increase right to left shunting. Strict avoidance of
decrease in SVR, decrease in venous return or myocardial
depression is of paramount importance.    
Both techniques regional or general anaesthesia can
be used.  Choice of induction agents for general anaesthesia
should be those agents which would cause least haemody-
mamic disturbance i.e. narcotic induction with etomidate.
Neonatal depression as a result of narcotic induction can be
easily treated with endotracheal intubation (ET) tube and no
further medical treatment is required. Regional technique
should be used with extreme caution.  Single shot spinal
anaesthesia should be avoided.  Slow induction of epidural
is advisable.6
Invasive monitoring is mandatory and arterial line or
CVP line is preferred to pulmonary artery (PA) catheter, as
risk outweighs the benefits.7 Complications include pul-
monary rupture8, thrombosis and in patient with a large
VSD or ASD, pulmonary wedge pressure may not reflect
left ventricular filling pressure. CVP may be more useful as
the right ventricle is at the greatest risk of dysfunction.1
Eisenmenger Syndrome is a complex combination of
cardiovascular abnormalities. It consists of pulmonary
hypertension, a right to left extra cardiac shunt and arterial
hypoxaemia.2 Pregnancy is not well tolerated by patients
with this condition. When pregnancy occurs in women with
Eisenmenger's syndrome, medical termination is considered
safer than any mode of delivery.6 Acute arrhythmias are
particularly dangerous as these patients have little or no car-
diac reserve and need a normal sinus rhythm to keep up with
the increased workload. Maternal mortality rate is estimat-
ed at 30-50%.
Pathophysiology of Eisenmenger syndrome is
described as a chronic, uncorrected right to left shunt, pro-
duces right ventricular hypertrophy (RVH), elevated pul-
monary artery pressure, and right ventricular (RV) dysfunc-
tion. The primary lesion may be either an ASD, VSD or
PDA.9 The pulmonary and the RV musculature undergoes
remodeling in response to the chronic pulmonary volume
overload, the high fixed pulmonary artery pressure limits
flow through the pulmonary vasculature and when pul-
monary artery pressure exceeds the level of systemic pres-
sure, reversal of shunt flow occurs.  The initial left to right
shunt becomes a right to left shunt, ultimately leading to the
Eisenmenger syndrome, which includes the sequelae of
arterial hypoxaemia, and RV failure. Clinical manifestations
include dyspneoa, clubbing of nails, polycythemia and
peripheral oedema and cynosis. In an established case of
Eisenmenger syndrome pulmonary hypertension when per-
manent, surgical correction of the defect at this stage is
unhelpful and may increase mortality.10
Anaesthetic management of patients with
Eisenmenger's syndrome is challenging. If the patient does
reach full term, a multidisciplinary approach with close
communication between obstetrician, cardiologist and
anaesthesiologist is essential. Anaesthetic consideration
centres on the avoidance of any decrease in the SVR.
Hypotension from any cause can progress to insufficient RV
pressure required to perfuse the hypertensive pulmonary
arterial bed and may result in sudden death of the patient.
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The anaesthetist must be aware of the maternal anticoagula-
tion. Both techniques regional and general anaesthesia may
be used,  if there are no contraindications to regional block,
a titrated epidural anaesthesia is probably the technique of
choice.6 A slow induction of epidural allows compensation
for sympathectomy below the level of block, a dilute solu-
tion of phenylephrine may be given as needed to maintain
maternal SVR.6 O2 should be administered to all patients
undergoing surgery under regional anaesthesia, as O2
reduces pulmonary vascular resistance, which benefits the
patient with Eisenmeneger.11 The blood loss should be
promptly replaced by crystalloids, colloids, or packed cells.
Postpartum autotransfusion may cause intravascular volume
overload in these patients. Regional anaesthesia may reduce
the risk of postoperative deep vein thrombosis.12
Caesarean section can also be conducted under gen-
eral anaesthesia, but there several disadvantages associated
with general anaesthesia6 e.g. effects of IPPV on venous
return, ventilation/perfusion mismatch, high pulmonary
artery pressure, increased shunt through the anatomic defect
and myocardial depression by halogenated agents. If slow
induction of anaesthesia is used there is a risk of maternal
aspiration.  Monitoring includes invasive blood pressure
monitoring (A-line), and central venous pressure (CVP)
monitoring.  Pulmonary artery catheter (PA) use is contro-
versial.7 It is difficult to position the balloon tipped flow
directed catheter into the pulmonary artery and risk of pul-
monary artery rupture is always present.8 Ampicilin and
gentamycin i.v. should be give as prophylaxis against infec-
tive endocarditis and repeated eight hourly after the initial
dose.
2. Valvular Heart Disease
In general regurgitant valvular lesions are well tol-
erated during pregnancy, where as stenotic lesions have a
greater potential for decompensation. Pregnant patients with
valvular heart disease can expect to have worsening of their
New York Heart Association (NYHA) functional class9,
some may develop CCF while others may have adverse
foetal outcome i.e. preterm birth or still birth.13
i) Mitral stenosis
Mitral stenosis occurs most commonly as a result
of rheumatic heart disease. Mitral stenosis is one of the most
common valvular lesion in parturient especially in the under
developed countries.2 Other valvular lesions like mitral
regurgitation, aortic stenosis and aortic regurgitation are
also associated with rheumatic fever, but are less frequent.
Pregnancy is detrimental to cardiac function in the
patient with mitral stenosis (MS) for several reasons. The
expanded blood volume can increase the risk of pulmonary
congestion and oedma. The physiological tachycardia in
pregnancy decreases the left ventricular (LV) filling time,
results in elevated left arterial pressure, can lead to oedema
and decreased onward flow of blood, resulting in hypoten-
sion, fatigue and syncope.9
Normal mitral valve orifice has a surface area of
4-6cms2 and symptoms develop when area is reduced to
2cms2 or less. Mitral valve stenosis prevents emptying of
the left atrium (LA), with increased left atrial and pul-
monary artery pressure, resulting in dyspnoea, haemoptysis
and pulmonary oedema.
Anaesthetic considerations are to maintain a slow
heart rate, venous return and SVR, avoid aorto-caval com-
pression, treat atrial fibrillation (AF) aggressively, try and
maintain sinus rhythm, prevent pain, hypoxaemia, hypercar-
bia and acidosis as these can increase PVR. Both general
anaesthesia and regional techniques have been used.
Anaesthetic options for caesarean section in patients with
mitral stenosis, must take into account the additional poten-
tial hazards of marked fluid shifts secondary to anaesthesia
technique and operative blood loss.
Epidural anaesthesia is preferred in patients with
mitral stenosis as the on-set of blockade is slow therefore
the haemodynamics are more controllable. Prophylactic
ephedrine administration should be avoided. If a need for
vaspressor arises, the drug of choice in patients with MS is
low dose phenylphrine.
General anaesthesia also provides a very stable
haemodynamic course, if the cardiovascular effects associ-
ated with laryngoscopy and intubation and oral suction are
minimized.  Induction agent should not produce wide
swings in the haemodynamics. Etomidate is a suitable
induction agent. A beta-blocker such as esmolol and a mod-
est dose of opioid should be administered before or during
the induction of general anaesthesia. Oxytocin should be
used with care, a dilute solution instead of bolus dose is rec-
ommended, and emergence must be carefully controlled to
avoid tachycardia.
ii) Mitral Regurgitation
Pure mitral regurgitation is rarely a problem.
Ischemic papillary muscle disease, myxomatus degenera-
tion, rheumatic fever and endocarditis are common causes,
and most patients with MR tolerate pregnancy well.
Regurgitation of blood through an incompetent
mitral valve results in chronic volume over load and dilata-
tion of the LV. Regurgitation may be acute or chronic. In the
acute type, there is acute pulmonary congestion and pul-
monary edema results. If the patient survives this episode of
acute mitral regurgitation, pulmonary artery pressure
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continues to increase and right heart failure occurs.
Pregnancy induces a hyper-coaguable state and systemic
embolism may occur in 20% patients with mitral regurgita-
tion.
Regional or general anaesthesia may be instituted.
Epidural anaesthesia prevents increase in SVR, promotes
forward flow of blood and helps to prevent pulmonary con-
gestion.1 Slow induction of epidural is indicated.
If general anaesthesia is required, ketamine and pan-
curonium are desirable agents in these patients.1 Atrial fib-
rillation (AF) must be treated promptly, and haemodynamic
instability associated with AF warrants immediate cardio-
version. Invasive (intra-arterial) BP monitoring, and pul-
monary artery catheter monitoring are advisable.
Antibiotic with pre-medication is recommended, as
these patients are prone to infective endocarditis. Primary
considerations are to maintain slightly increased heart rate,
to prevent increase in SVR, increase in the central blood
volume, and prevent hypoxemia, hypercarbia, acidosis
which may increase PVR, avoid aortocaval compression
and myocardial depression. 
iii) Aortic stenosis
(AS) rarely complicates pregnancy. The natural his-
tory of this lesion, require 3-4 decades to reach severity to
produce symptoms.2 However, bicuspid aortic valve is the
most common congenital anomaly of the heart.9 The patho-
physiology of severe AS entail a narrowing of the valve to
less than 1 cm2 associated with a trans-vascular gradient of
50mmHg with significant increase in after load to the LV. A
valvular gradient which exceeds 100mmHg, there is an
increased risk of myocardial ischemia as the LV hypertro-
phies significantly.2
In aortic stenosis transvascular gradient increases
progressively throughout pregnancy, due to increasing
blood volume and decreasing SVR.
Anaesthetic management in AS is to avoid tachycar-
dia, and bradycardia, maintain intravascular volume and
venous return, avoid aortocaval compression, and myocar-
dial depression, maintain a normal heart rate as a slow heart
rate decreases cardiac output (CO). Tachycardia may
decrease time for coronary perfusion of the hypertrophied
LV. Arrhythmias are not well tolerated and should be
promptly treated. Patients with trans-vascular gradient more
than 50mmHg with symptomatic AS should have invasive
monitoring i.e. A-line and PA catheter in place.
General or regional anaesthesia is used.
Traditionally epidural analgesia is contraindicated due to
the risk of fall in SVR, resulting in hypotension, poorly tol-
erated in patients with a fixed cardiac output. Neuraxial
block for aortic stenosis has become an accepted technique
but remains controversial1.4 Regional anaesthesia for cae-
sarean section in patients with aortic stenosis has been
described in several reports.l4
General Anaesthesia should be accomplished with
the same caution that applies to MS. Drugs of choice are a
combination of etomidate and modest dose of opioids with
succinylcholine for rapid sequence intubation. Myocardial
depression associated with volatile anaesthetic agents
should be avoided.  Oxytocin should be avoided as it is
known to cause marked vasodilation, with hypotension. The
drug of choice for uterine contraction is ergometrine at the
end of delivery.
PA catheter monitoring is controversial7, as it entails
a high risk of ventricular arrhythmias and cardiovascular
collapse.1 CVP monitoring is desirable and should be main-
tained at a high normal level to protect cardiac output dur-
ing unexpected peri-partum haemorrhage.
iv) Aortic insufficiency
This may be congenital or acquired. Rheumatic
fever is a cause in 75% of cases. 
The pathophysiology is of chronic volume overload
of the LV, with hypertrophy and dilatation and increase in
LV End Diastolic Volume (LVEDV), decrease in ejection
fraction (EF) and signs and symptoms of pulmonary edema.
Patients with aortic insufficiency tolerate pregnancy well as
pregnancy results in a modest increase in heart rate.
Anaesthetic considerations focus on minimizing pain to pre-
vent catecholamine - induced increases in SVR and avoid
bradycardia, which may increase regurgitant flow.
Epidural anaesthesia is preferred as it decreases the
after-load, and prevents increases in SVR and acute LV vol-
ume overload in these patients. If the patient is on anticoag-
ulant, RA posses a risk of epidural / spinal haematoma.1
General anaesthesia may be induced with etomidate
to prevent severe haemodynamic swings, followed by intu-
bation of the trachea with suxamethonium. Remi-fentanil is
the drug of choice to provide analgesia. It is used as an infu-
sion during induction and maintenance of anaesthesia and
provides haemodynamic stability. Neonatal respiratory
depression is known to occur with remi-fentanil. It is treat-
ed with endotracheal intubation and no further medical
management is required for the neonate.15
v) Congenital Mitral Valve Prolaspe
(MVP) is much more comon among pregnant
women, and the reported incidence is 10-17% of all preg-
nancies.16 Women with MV pro lapse usually tolerate preg-
nancy well.
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Pathophysiology is a primary idiopathic MVP char-
acterized by a redundant valve that prolapses into the ven-
tricle during systole. It is a benign condition and most
patients are asymptomatic, however some may develop
symptoms of chest pain, dyspnoea, weakness and palpita-
tion.
Anaesthetic consideration is to avoid decrease in
cardiac output, heart rate and LV End Diastolic Pressure
(LVEDP) as this can exaggerate the prolapse.  
Both regional and general anaesthesia can be insti-
tuted. Regional anaesthesia is an excellent choice for cae-
sarean delivery.1 Epidural anaesthesia is the technique of
choice.  Slow induction with low dose local anaesthetic
agent and an opioid is advised.
During general anaesthesia all sympathomimetic
agents should be avoided, because of high incidence of
arrhythmias. Hypotension can be treated with small boluses
of phenylephrine.
vi) Prosthetic valves
A pregnant patient with a prosthetic valve is at a high
risk of foetal and maternal complications. Maternal compli-
cations include thrombo-embolic phenomena, valve failure
and bacterial endocarditis. Foetal complications include
foetal haemorrhage due to maternal anticoagulation and ter-
atogenicity. Porcine heterografts are best choice for women
of child bearing age who wish to become pregnant. Both
regional and general anaesthesia can be given safely.
Regional anaesthesia is preferred in these patients
but the chronic use of heparin may result in thrombocytope-
nia and continuous anticoagulant therapy is a contraindica-
tion for regional analgesia.2
When general anaesthesia is required in these anti-
coagulated patients, residual valvular or myocardial dys-
function will influence the choice of anaesthetic drugs and
the use of additional monitoring i.e. CVP, PA catheter and
A-line are recommended.
3. Primary Pulmonary Hypertension
Pulmonary hypertension and pregnancy is a lethal
combination.17 Patients with this condition are advised to
avoid pregnancy, preferably by tubal ligation as contracep-
tive drugs are shown to accelerate the progression of the dis-
ease.17
Main feature of this syndrome is raised pulmonary
artery pressure, unlike the Eisenmernger syndrome, the pul-
monary vascular tone in this condition responds to vasodila-
tor agents.1
Anaesthetic management is similar to that of the
Eisenmenger syndrome. Elective caesarean section is the
preferred method of delivery.18 Both regional and general
anaesthesia can be used for caesarean delivery. For regional
anaesthetic technique using a slow induction epidural
anaesthesia is advised. Vasopressors are only used if
absolutely necessary, as they increase pulmonary artery
pressure.19 A continuous spinal technique (CSA) has been
described using a catheter and incremental injection of local
anaesthesia producing a predictable block and a lower inci-
dence of hypotension.20,21 Recently the use of nitric oxide
(NO), a potent vasodilator has become popular for patients
with primary pulmonary hypertension. There are few
reports of its use in pregnancy.1
4. Peripartum Cardio-Myopathy (PPCM)
PPCM was first defined in 1971 as symptoms of
heart failure that become apparent in the last month of preg-
nancy or within 5 months postpartum in patients who have
no pre-existing heart disease and no other obvious etiology
for heart failure.9 Recently echo-cardiographic criteria
including EF less than 45% and diastolic dimension greater
than 2.72cm/m2 for the diagnosis were established by
Hibbard et al. Peri-partum cardio-myopathy is a serious
myocardial disease of a dilative nature where the patient
presents with heart failure in the 3rd trimester of pregnancy.
Reported incidence is 1 in 4000 and 1 in 10,00022 and mor-
tality rate is 18%-50%.22 It could be Viral, autoimmune or
toxic in nature. Other factors e.g. nutritional deficiencies,
small vessel coronary artery disease, myocarditis, pregnan-
cy related exacerbation of the pre-existing cardio-myopathy
of some form, may play a role in the etiology.1 Initially,
symptoms are of mild upper respiratory tract infection,
chest congestion and fatigue, these symptoms can progress
to rapid florid cardiac failure with biventricular hypokine-
sia. Principles of anaesthetic management are same as those
for severe cardio-myopathy. Primary goals are to avoid
myocardial depressants, and cautious fluid management
with judicious use of diuretics and vasodilators, (mainte-
nance of normal heart rate and sinus rhythm). Both region-
al and general anaesthesia can be used with extreme cau-
tions.
Very recently continuous spinal anaesthesia (CSA)
was successfully employed as an anaesthetic technique for
caesarean section delivery in PPCM. Using low dose local
anaesthesia and opioids combination which is slowly titrat-
ed23, CSA appears to offer more haemodynamic stability
than a single dose of spinal anaesthesia for caesarean sec-
tion.19 Invasive monitoring is required, including PA
catheter. A-line is necessary when using general anaesthe-
sia. Potential hazards such as increased pulmonary artery
pressure during laryngoscopy and intubation, the adverse
effects of IPPV on venous return and the negative inotropic
36 J Pak Med Assoc
effects of certain anaesthetic agents should be kept in mind.
These effects can however be minimized by the use of nar-
cotic based induction and maintenance of anaesthesia.
5. Maternal arrhythmias during pregnancy
Management of arrhythmias during pregnancy is
similar to that in the non-pregnant patient.1
Catecholamine sensitive ventricular tachycardia (VT)
Majority of VTs are due to re-entry, and may appear
for the first time during gestation.24 Patients with a prior his-
tory of VT should continue their anti-arrhythmic medication
throughout pregnancy.   Slow incremental CSE is the rec-
ommended technique24 of choice.   
Congenital heart block and bradyarythmias
If congenital heart block is recognized in a pregnant
woman, cardiac consultation should be taken, to determine
whether there is need of a pacemaker. A pacemaker is indi-
cated in patients with symptoms, when Q-T interval is pro-
longed or there is left atrial enlargement.  Equipment as
CVP access tray, and trans-venous pacing wires should be
ready at patient’s bedside during caesarean delivery, in the
event of rapid intervention.25 Epidural analgesia is recom-
mended for caesarean section delivery.
Postoperative period in parturients with cardiac dis-
ease
In the postoperative period, patients with severe car-
diac dysfunction delivered by Caesarean section should be
kept in the High Dependent Unit (HDU) / intensive care unit
(ICU) for aggressive monitoring of fluid therapy, oxygen
saturation and haemodynamics. During the first 24-72 hours
significant fluid shift occurs, which may lead to CCF.
Adequate post-operative analgesia should be provided in
the form of continuous epidural analgesia or patient con-
trolled IV analgesia. Early ambulation to minimize the risk
of deep venous thrombosis and paradoxical embolization
should be weighed against the risk of cardiovascular
stress.26
Foetal and maternal outcome in Caesarean delivery in
patients with cardiac disease
The optimal management of these patients requires
cooperative efforts of the obstetrician, cardiologist and the
anaesthesiologist involved in the care of these high risk
patients.26,27 Classification of these patients according to the
New York Heart Association (NHA) correlates best with the
maternal outcome.28 Mortality rate of less than 1% is report-
ed in Class I and II while in class III and IV it is between 5-
15%.29
Summary 
The current status of a parturient with cardiac dis-
ease has become safer with improvement in treatment and
management. Patients with cardiac disease were strongly
discouraged in the past from becoming pregnant, now with
vast improvement in cardiac care and advances in reproduc-
tive technology, more women with cardiac disease are plan-
ning pregnancy. The management of parturients with severe
cardiac ailments is not anymore “one man's show”.26 The
cardiologist, obstetrician and the anaesthesiologist should
jointly analyze and discuss the cardiac problem and to make
a rational choice of the management. The skill and experi-
ence of the anaesthesiologist on common potential intra-
operative problems, the ability to respond quickly to haemo-
dynamic disturbances are far more important than the spe-
cific technique or agent used.
The advantage of regional anaesthesia is that the
patient can report any symptoms as palpitations, chest pain
and shortness of breath, so that prompt action can be
taken.26 Regional anaesthesia should be established with
low dose of LA, and an opioid. The induction of the epidur-
al should be slow to prevent acute episodes of hypotension.
If general anaesthesia is required, the standard technique of
rapid sequence induction is employed, which does little to
blunt the stress response.
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